Benjamin Paluch

Stock Analyst at Roth MKM

(1.33)

# 3,546

Out of 5,182 analysts

3

Total ratings

33.33%

Success rate

0.8%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Benjamin Paluch

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CGON CG Oncology	Initiates: Buy	$65	$67.48	-3.68%	1	Aug 27, 2024
	REPL Replimune Group	Initiates: Buy	$17	$8.41	+102.14%	1	Aug 27, 2024
	GNLX Genelux	Initiates: Buy	$10	$2.57	+289.11%	1	Aug 27, 2024

CG Oncology

Aug 27, 2024

Initiates: Buy

Price Target: $65

Current: $67.48

Upside: -3.68%

Replimune Group

Aug 27, 2024

Initiates: Buy

Price Target: $17

Current: $8.41

Upside: +102.14%

Genelux

Aug 27, 2024

Initiates: Buy

Price Target: $10

Current: $2.57

Upside: +289.11%